The clinical value of holmium laser enucleation of the prostate in octogenarians.
BPH
LUTS
age
benign prostatic enlargement
elderly
holmium laser enucleation of the prostate
Journal
Lower urinary tract symptoms
ISSN: 1757-5672
Titre abrégé: Low Urin Tract Symptoms
Pays: Australia
ID NLM: 101506777
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
revised:
28
10
2020
received:
17
09
2020
accepted:
06
11
2020
pubmed:
2
12
2020
medline:
29
10
2021
entrez:
1
12
2020
Statut:
ppublish
Résumé
With holmium laser enucleation of the prostate (HoLEP) a size-independent method for surgical treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO) has been introduced. HoLEP offers durable long-term results with reduced perioperative morbidity. As the risk of disease progression increases with age, the main goals, when offering surgery to an elderly population, are reducing perioperative morbidity and preserving quality of life (QoL). We therefore analyzed the impact of age on outcomes and perioperative morbidity in patients undergoing HoLEP for LUTS at our tertiary referral center. We retrospectively collected data of 487 patients who underwent HoLEP for LUTS secondary to BPO between 2018 and 2019. Patients were divided into group 1 (<70 years), group 2 (70-79 years), and group 3 (≥80 years). Perioperative parameters, safety, and short-term functional outcomes were assessed and analyzed. Perioperative Clavien-Dindo grade ≥II complications were seen in 4.1% of patients (20/487). There was no difference in perioperative complications between all age groups (P = .176). Functional outcome was assessed 30 days post surgery. There was significant improvement in median International Prostate Symptom Score of 14, 10, and 8 points for groups 1, 2, and 3 (P < .001), respectively, with constant improvement of median QoL of 3 points for all groups. Median maximum flow rate (Q HoLEP offers acceptable perioperative complication rates even in the oldest patient cohort (≥80 years). Therefore, HoLEP is a safe and efficient option even in oldest patients.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
279-285Informations de copyright
© 2020 The Authors. LUTS: Lower Urinary Tract Symptoms published by John Wiley & Sons Australia, Ltd.
Références
Gilling PJ, Cass CB, Cresswell MD, Fraundorfer MR. Holmium laser resection of the prostate: preliminary results of a new method for the treatment of benign prostatic hyperplasia. Urology. 1996;47:48-51.
Suardi N, Gallina A, Salonia A, et al. Holmium laser enucleation of the prostate and holmium laser ablation of the prostate: indications and outcome. Curr Opin Urol. 2009;19:38-43.
Ahyai SA, Gilling P, Kaplan SA, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010;58:384-397.
Ibrahim A, Alharbi M, Elhilali MM, Aube M, Carrier S. 18 years of holmium laser Enucleation of the prostate: a single center experience. J Urol. 2019;202:795-800.
Magistro G, Westhofen T, Stief CG, Weinhold P. A matched-pair analysis of patients with medium-sized prostates (50 cc) treated for male LUTS with HoLEP or TURP. Low Urin Tract Symptoms. 2020;12:117-122.
Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol. 2008;53:160-166.
Humphreys MR, Miller NL, Handa SE, Terry C, Munch LC, Lingeman JE. Holmium laser enucleation of the prostate-outcomes independent of prostate size? J Urol. 2008;180:2431-2435.
Elzayat EA, Habib EI, Elhilali MM. Holmium laser enucleation of the prostate: a size-independent new “gold standard”. Urology. 2005;66:108-113.
Ali TF, Warkentin LM, Gazala S, Wagg AS, Padwal RS, Khadaroo RG. Self-reported outcomes in individuals aged 65 and older admitted for treatment to an acute care surgical service: a 6-month prospective cohort study. J Am Geriatr Soc. 2015;63:2388-2394.
Gazala S, Tul Y, Wagg A, Widder SL, Khadaroo RG, Acute Care and Emergency Surgery (ACES) Group. Quality of life and long-term outcomes of octo- and nonagenarians following acute care surgery: a cross sectional study. World J Emerg Surg. 2013;8:23.
Goldspink DF. Ageing and activity: their effects on the functional reserve capacities of the heart and vascular smooth and skeletal muscles. Ergonomics. 2005;48:1334-1351.
Gravas S, Cornu, J. N., Drake, M. J., Gacci, M., Gratzke, C., Herrmann, T. R. W., Madersbacher, S., Mamoulakis, C., Tikkinen, K. A. O. Management of Non-neurogenic Male LUTS. EAU Guidelines Edn presented at the EAU Annual Congress Copenhagen 2018. 2018.
Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187-196.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213.
Mamoulakis C, Efthimiou I, Kazoulis S, Christoulakis I, Sofras F. The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostate. World J Urol. 2011;29:205-210.
Roosen A, Gratzke C, Herrlemann A, et al. Etiology and pathophysiology of benign prostate hyperplasia. Der Urol Ausg A. 2013;52:186-192.
Uchida T, Ohori M, Soh S, et al. Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Urology. 1999;53:98-105.
Ahyai SA, Chun FK, Lehrich K, et al. Transurethral holmium laser enucleation versus transurethral resection of the prostate and simple open prostatectomy-which procedure is faster? J Urol. 2012;187:1608-1613.
Steinmeyer Z, Delpierre C, Soriano G, et al. Hemoglobin concentration; a pathway to frailty. BMC Geriatr. 2020;20:202.
Donoghue TJ. Assessing frailty and its implications on anesthesia care and postoperative outcomes in surgical patients. AANA J. 2019;87:152-159.
Mmeje CO, Nunez-Nateras R, Warner JN, Humphreys MR. Age-stratified outcomes of holmium laser enucleation of the prostate. BJU Int. 2013;112:982-989.
Lee KH, Kuo HC. Recovery of voiding efficiency and bladder function in male patients with non-neurogenic detrusor Underactivity after transurethral bladder outlet surgery. Urology. 2019;123:235-241.
Aldamanhori R, Chapple CR. Underactive bladder, detrusor underactivity, definition, symptoms, epidemiology, etiopathogenesis, and risk factors. Curr Opin Urol. 2017;27:293-299.
Welk B, McGarry P, Baverstock R, Carlson K, Hickling D. Do urodynamic findings other than outlet obstruction influence the decision to perform a transurethral resection of prostate? Urology. 2018;117:120-125.
Elshal AM, Elmansy HM, Elhilali MM. Transurethral laser surgery for benign prostate hyperplasia in octogenarians: safety and outcomes. Urology. 2013;81:634-639.
Westhofen T, Schott M, Keller P, Tamalunas A, Stief C, Magistro G. Superiority of HoLEP over TURP in a matched-pair analysis of bleeding complications under various antithrombotic regimens. J Endourol. 2020. Online ahead of print.
Balslev Jorgensen J, Seidelin C, Petersen F, Frimodt-Moller C. Does old age contraindicate TURP. Eur Urol. 1997;31:281-285.